{"protocolSection":{"identificationModule":{"nctId":"NCT06073574","orgStudyIdInfo":{"id":"ION-682884-CS2MRI"},"secondaryIdInfos":[{"id":"2019-002835-27","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"Ionis Pharmaceuticals, Inc.","class":"INDUSTRY"},"briefTitle":"CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study","officialTitle":"The CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study"},"statusModule":{"statusVerifiedDate":"2025-11","overallStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-03-31","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-03","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-04","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-10-04","studyFirstSubmitQcDate":"2023-10-04","studyFirstPostDateStruct":{"date":"2023-10-10","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-11-25","lastUpdatePostDateStruct":{"date":"2025-11-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Ionis Pharmaceuticals, Inc.","class":"INDUSTRY"},"collaborators":[{"name":"AstraZeneca","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":true},"descriptionModule":{"briefSummary":"The main purpose of this study is to measure the amyloid burden, defined as extracellular volume (ECV) assessed by Magnetic Resonance Imaging (MRI) over time in a subset of up to 150 participants enrolled in ION-682884-CS2 (NCT04136171).","detailedDescription":"This pilot study will determine the efficacy of ION-682284 in reducing the amyloid deposit on the heart tissue compared to placebo."},"conditionsModule":{"conditions":["Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)"],"keywords":["TTR","Amyloidosis","Cardiomyopathy"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":150,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Experimental: ION-682884-CS2 MRI Scan Sub-set","description":"Participants enrolled in the parent study ION-682884-CS2 (NCT04136171) to receive either eplontersen or placebo and who consented to participate in this sub-study will undergo cardiac MRI at Baseline, Weeks 25, 49, 97 and 140.","interventionNames":["Diagnostic Test: Cardiac MRI"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"Cardiac MRI","description":"MRI Scans as specified in the corresponding arm group.","armGroupLabels":["Experimental: ION-682884-CS2 MRI Scan Sub-set"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in the Percent of ECV in Participants Receiving ION-682884 vs. Placebo According to ION-682884-CS2 Treatment Groups","timeFrame":"From Baseline up to Week 140"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nTo participate in the ION-682884-CS2MRI sub-study, participants must meet all inclusion criteria of the study protocol ION-682884-CS2 (NCT04136171).\n\nExclusion Criteria\n\n1. Contraindication or sensitivity to MRI contrast agents\n2. Orthopnea of sufficient severity to preclude supine scanning at screening.\n3. Weight or body girth exceeds the limits of the cardiac MRI machine specifications.\n4. Contraindication to cardiac MRI scanning, as assessed by local MRI safety questionnaire/checklist.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"90 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Participants who were randomized in Study ION-682884-CS2 (NCT04136171) and who signed informed consent for the MRI sub-study will participate in this sub-study.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"locations":[{"facility":"Brigham and Women's Hospital","city":"Boston","state":"Massachusetts","zip":"02115","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Oregon Health and Science University","city":"Portland","state":"Oregon","zip":"97239","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"Azienda Ospedaliero - Universitaria Careggi","city":"Florence","zip":"50139","country":"Italy","geoPoint":{"lat":43.77925,"lon":11.24626}},{"facility":"Azienda Ospedale Universit√† di Padova","city":"Padua","zip":"35128","country":"Italy","geoPoint":{"lat":45.40797,"lon":11.88586}},{"facility":"Hospital Universitario Puerta de Hierro","city":"Majadahonda","zip":"28222","country":"Spain","geoPoint":{"lat":40.47353,"lon":-3.87182}},{"facility":"Synexus - Scotland Clinical Research Centre","city":"Bellshill","zip":"ML4 3NJ","country":"United Kingdom","geoPoint":{"lat":55.81667,"lon":-4.01667}},{"facility":"Synexus Midlands Clinical Research Centre","city":"Birmingham","zip":"B15 2SQ","country":"United Kingdom","geoPoint":{"lat":52.48142,"lon":-1.89983}},{"facility":"Synexus - Wales","city":"Cardiff","zip":"CF15 9SS","country":"United Kingdom","geoPoint":{"lat":51.48,"lon":-3.18}},{"facility":"Royal Free London NHS Foundation Trust","city":"London","zip":"NW3 2QG","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Richmond Pharmacology","city":"London","zip":"SE1 1YR","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Synexus - Manchester Clinical Research Centre","city":"Manchester","zip":"M15 6SE","country":"United Kingdom","geoPoint":{"lat":53.48095,"lon":-2.23743}}]},"referencesModule":{"seeAlsoLinks":[{"label":"CARDIO-TTransform Website","url":"https://www.cardio-ttransform.com/"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-02-25"},"conditionBrowseModule":{"meshes":[{"id":"D000686","term":"Amyloidosis"},{"id":"D009202","term":"Cardiomyopathies"}],"ancestors":[{"id":"D057165","term":"Proteostasis Deficiencies"},{"id":"D008659","term":"Metabolic Diseases"},{"id":"D009750","term":"Nutritional and Metabolic Diseases"},{"id":"D006331","term":"Heart Diseases"},{"id":"D002318","term":"Cardiovascular Diseases"}]}},"hasResults":false}